Su-fang Chen

Key Laboratory Of Renal Disease
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Association of FHR5 With Disease Severity in ANCA-Associated Vasculitis.

Association of FHR5 With Disease Severity in ANCA-Associated Vasculitis.

Journal: Kidney international reports

Published: January 28, 2026

Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: RMD open

Published: October 13, 2025

Canagliflozin Alleviates Experimental ANCA-Associated Vasculitis through Suppression of Pathogenic T-Cell Responses.

Canagliflozin Alleviates Experimental ANCA-Associated Vasculitis through Suppression of Pathogenic T-Cell Responses.

Journal: Journal of the American Society of Nephrology : JASN

Published: September 11, 2025

Neutrophil CD11b is a pivotal PANoptosis marker correlated with disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.

Neutrophil CD11b is a pivotal PANoptosis marker correlated with disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 24, 2025

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook.

Journal: Kidney diseases (Basel, Switzerland)

Published: April 03, 2024

FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα-CPT1a pathway.

FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα-CPT1a pathway.

Journal: Rheumatology (Oxford, England)

Published: June 04, 2023

A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis.

A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Journal: BMC medicine

Published: September 06, 2022

Inhibitor of apoptosis proteins antagonist SM164 ameliorates experimental MPO-ANCA-associated vasculitis via enhancing fatty acid oxidation in neutrophils.

Inhibitor of apoptosis proteins antagonist SM164 ameliorates experimental MPO-ANCA-associated vasculitis via enhancing fatty acid oxidation in neutrophils.

Journal: Rheumatology (Oxford, England)

Published: April 04, 2022

Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Journal: Frontiers in medicine

Published: September 02, 2021

Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner.

Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner.

Journal: Clinical science (London, England : 1979)

Published: April 21, 2020

Complement Activation in Progression of Chronic Kidney Disease.

Complement Activation in Progression of Chronic Kidney Disease.

Journal: Advances in experimental medicine and biology

Published: August 11, 2019

Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis.

Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis.

Journal: Kidney international

Published: August 23, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026